Previous research in our laboratory suggests that serotonin (5-HT) neurotra
nsmission mediates the expression of cocaine-induced convulsions. The role
of 5-HT in mediating this toxic effect of cocaine appears to be due to acti
vation of 5-HT, receptors, because cocaine-induced convulsions are blocked
by the 5-HT, antagonists cinanserin, ketanserin, and pirenperone. The prese
nt study utilized a number of compounds that display a high affinity for 5-
HT2 receptors to further examine the role of these sites in mediating this
toxic effect of cocaine. Cocaine-induced convulsions were observed followin
g pretreatment with various doses of the following 5-HT2 antagonists: mians
erin, metergoline, MDL 11939, and methiothepin. In addition, 1-(2-methoxyph
enyl)-4-[4-(2-phthalimido)butyl]piperazine (NAN 190) was tested to examine
the influence of 5-HT1 sites and the agonist compound 1-(3-triflurormethylp
henyl)piperazine (TFMPP) was examined to further explore the role of 5-HT1
and 5-HT2, sites. Each 5-HT2 antagonist attenuated cocaine-induced convulsi
ons. Conversely, NAN 190 did not alter this toxic effect of cocaine. In add
ition, TFMPP significantly potentiated cocaine-induced convulsions. The res
ults from this study support the hypothesis that 5-HT neurotransmission, ac
ting primarily at 5-HT2 receptors, plays an important role in mediating coc
aine-induced convulsions. (C) 2000 Elsevier Science Inc.